Freedom Investment Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-23,364
Closed -$2.32M 734
2019
Q3
$2.32M Sell
23,364
-6,794
-23% -$646K 0.2% 102
2019
Q2
$2.79M Sell
30,158
-43,643
-59% -$4.14M 0.23% 87
2019
Q1
$6.96M Sell
73,801
-6,375
-8% -$558K 0.56% 29
2018
Q4
$5.14M Buy
80,176
+17,419
+28% +$1.29M 0.4% 33
2018
Q3
$5.75M Sell
62,757
-2,457
-4% -$217K 0.36% 35
2018
Q2
$5.18M Buy
65,214
+18,393
+39% +$1.53M 0.31% 37
2018
Q1
$4.18M Buy
46,821
+2,254
+5% +$216K 0.21% 64
2017
Q4
$4.65M Buy
44,567
+4,402
+11% +$497K 0.24% 42
2017
Q3
$5.86M Buy
40,165
+5,685
+16% +$774K 0.32% 34
2017
Q2
$4.48M Buy
34,480
+9,599
+39% +$1.18M 0.26% 41
2017
Q1
$3.1M Sell
24,881
-1,350
-5% -$162K 0.18% 67
2016
Q4
$3.04M Sell
26,231
-5,980
-19% -$666K 0.19% 55
2016
Q3
$3.37M Sell
32,211
-280
-0.9% -$30.3K 0.22% 49
2016
Q2
$3.21M Buy
32,491
+2,265
+7% +$234K 0.22% 43
2016
Q1
$3.02M Sell
30,226
-1,940
-6% -$200K 0.22% 44
2015
Q4
$3.85M Buy
32,166
+27,976
+668% +$3.24M 0.29% 38
2015
Q3
$617K Sell
4,190
-20,190
-83% -$2.51M 0.06% 275
2015
Q2
$2.82M Buy
24,380
+5,042
+26% +$576K 0.29% 48
2015
Q1
$2.23M Buy
19,338
+5,112
+36% +$611K 0.25% 55
2014
Q4
$1.59M Buy
14,226
+3,667
+35% +$387K 0.21% 68
2014
Q3
$1M Buy
10,559
+2,204
+26% +$199K 0.18% 92
2014
Q2
$718K Buy
8,355
+871
+12% +$66.2K 0.12% 148
2014
Q1
$522K Buy
7,484
+280
+4% +$22.2K 0.11% 180
2013
Q4
$609K Buy
7,204
+894
+14% +$70.7K 0.15% 123
2013
Q3
$486K Buy
6,310
+982
+18% +$68.8K 0.14% 122
2013
Q2
$312K Buy
+5,328
New +$321K 0.11% 170

Other funds holding CELG

Freedom Investment Management's CELG Position: Q4 2019 in Review

Freedom Investment Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 23,364 shares — an estimated $2.32M sold.

Freedom Investment Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $6.96M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Freedom Investment Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Freedom Investment Management sold 23,364 Celgene Corp shares in Q4 2019, an estimated $2.32M.
  • Freedom Investment Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Freedom Investment Management's Celgene Corp position peaked at $6.96M in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Freedom Investment Management's 13F filing for Q4 2019, filed 24 Jan 2020.